Analysis

Analysis

Fennec Pharmaceuticals 2025 Financial Update

 Company Overview Fennec Pharmaceuticals Inc. is a specialty pharmaceutical company committed to the fight against ototoxicity in cancer...

March 25, 2026 | 1 min read | $FENC

Analysis

NVIDIA (NVDA) Re-Entry Into China’s AI Chip Market: Products, Policy, Competition, and Investor Impact

NVIDIA (NVDA) is positioning for a potential re-acceleration of data center growth by adapting its AI accelerator lineup...

March 24, 2026 | 26 min read | $NVDA

Analysis

Avalo Therapeutics 2025 Financial Review

Company Overview Avalo Therapeutics is a clinical-stage biotechnology company dedicated to developing IL-1β-based treatments for immune-mediated inflammatory diseases....

March 24, 2026 | 1 min read | $AVTX

Analysis

WeRide Inc. 2025 Financial Performance Review

Company Overview WeRide Inc. is a global leader in autonomous driving technology and the first publicly traded robotaxi...

March 24, 2026 | 1 min read | $WRD

Analysis

Surrozen 2025 Financial Results Review

Company Overview Surrozen is a biotechnology company developing targeted therapeutics that harness Wnt signaling to address sight-threatening ophthalmic...

March 24, 2026 | 1 min read | $SRZN

Analysis

PPHC Q4 and FY 2025 Financial Review

Company Overview Public Policy Holding Company, Inc. (PPHC) is a global strategic communications provider offering advisory services across...

March 24, 2026 | 1 min read | $PPHC

Analysis

Cabaletta Bio Q4 and FY 2025 Financial Review

Company Overview Cabaletta Bio is a late-stage clinical biotechnology company focused on developing targeted cell therapies specifically for...

March 24, 2026 | 1 min read | $CABA

Analysis

Arbutus Biopharma 2025 Financial Review

 Company Overview Arbutus Biopharma Corporation is a clinical-stage biopharmaceutical company focused on infectious diseases.  Key Financial Figures For...

March 24, 2026 | 1 min read | $ABUS

Analysis

Sutro Biopharma 2025 Financial Review

Company Overview Sutro Biopharma is a clinical-stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs). Key...

March 24, 2026 | 1 min read | $STRO

Analysis

Talphera Q4 and Full Year 2025 Financial Update

Company Overview Talphera is a specialty pharmaceutical company developing therapies for medically supervised settings. They are currently advancing...

March 24, 2026 | 1 min read | $TLPH

Analysis

Context Therapeutics 2025 Financial Review

Company Overview Context Therapeutics is a clinical-stage biopharmaceutical company developing T cell engaging bispecific antibodies for solid tumors....

March 24, 2026 | 1 min read | $CNTX

Analysis

Lithium Argentina 2025 Financial Review

Company Overview Lithium Argentina produces lithium carbonate primarily for the electric vehicle and battery markets. The company operates...

March 24, 2026 | 1 min read | $LAR